Novo Nordisk takes legal action over copycat weight loss medication ...Middle East

The Hill - News
Novo Nordisk takes legal action over copycat weight loss medication
Pharmaceutical company Novo Nordisk is pursuing legal action against two compounding pharmacies for allegedly offering contaminated copycat versions of the drug semaglutide, found in weight-loss medication like Ozempic and Wegovy. The company said it had conducted tests on the compounded drug being sold from two Florida pharmacies and found one sample from Wells Pharmacy had an impurity level of 33 percent and Brooksville Pharmaceuticals had at least 19 percent less semaglutide than advertised. Semaglutide is patented by Novo Nordisk. The company filed two lawsuits Wednesday night to warn patients that the compounded drugs are not approved by the Food and Drug Administration (FDA) a

Hence then, the article about novo nordisk takes legal action over copycat weight loss medication was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk takes legal action over copycat weight loss medication )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
myMOTHERLODE - before 6 hours & 51 minute